Each week we present you with the latest featured study from the research teams at JAMA, Journal of the American Medical Association. Check out the video for intriguing…
Each week we present you with the latest featured study from the research teams at JAMA, Journal of the American Medical Association. Check out the video for intriguing…
NEW YORK (Reuters Health) – Dasatinib, a second-generation dual-specific BCR-ABL kinase inhibitor penetrates the blood-brain barrier and has promising therapeutic potential for Philadelphia chromosome-positive leukemia that has spread…
NEW YORK (Reuters Health) – Topical gabapentin is a well tolerated, effective treatment for relieving the pain of localized and generalized vulvodynia, according to a report in the…
In a recent study, diabetics who took both insulin and other medications for the disease had fewer plaques associated with Alzheimer’s disease than other patients. References and Resources…
According to preliminary evidence, taking the epilepsy drug Topiramate (Topamax) during early pregnancy may increase the risk of birth defects. References and Resources Hunt S, Russell A, Smithson…
Myriad Genetics, Inc. is discontinuing development of tarenflurbil, also known as Flurizan, after the investigational treatment for Alzheimer’s disease failed to achieve significance on the co-primary endpoints –…
The FDA has expanded indications for methylphenidate (Concerta) extended-release tablets to include adults aged 18 to 65 with ADHD. For more information visit: FDA Sponsored by The Doctor’s…
According to a small multi-center, phase II trial reported in NEJM, an investigational targeted drug for some patients with metastatic thyroid cancer can induce partial responses. References and…
According to results of a multi-center, placebo-controlled phase IIb trial, patients treated with laquinimod, a new type of immumodulatory agent for relapsing-remitting MS, had a 40% reduction in…
In a randomized placebo-controlled phase III trial called TIGER-1, the investigational cystic fibrosis drug denufosol significantly improved large airway function. Sponsored by The Doctor’s Channel
As presented at ASCO, second-line bevacizumab (Avastin) as monotherapy has been associated with a 28% response rate and an overall survival edge for refractory glioblastoma. Also presented at…
